These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8941995)

  • 1. RASSE: a new method for structure-based drug design.
    Luo Z; Wang R; Lai L
    J Chem Inf Comput Sci; 1996; 36(6):1187-94. PubMed ID: 8941995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new procedure for improving the predictiveness of CoMFA models and its application to a set of dihydrofolate reductase inhibitors.
    Kroemer RT; Hecht P
    J Comput Aided Mol Des; 1995 Oct; 9(5):396-406. PubMed ID: 8594157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
    Fogel GB; Cheung M; Pittman E; Hecht D
    J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure-based design and synthesis of selective inhibitors of Trypanosoma cruzi dihydrofolate reductase.
    Zuccotto F; Brun R; Gonzalez Pacanowska D; Ruiz Perez LM; Gilbert IH
    Bioorg Med Chem Lett; 1999 May; 9(10):1463-8. PubMed ID: 10360757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation.
    Nishibata Y; Itai A
    J Med Chem; 1993 Oct; 36(20):2921-8. PubMed ID: 8411008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-organizing neural networks for modeling robust 3D and 4D QSAR: application to dihydrofolate reductase inhibitors.
    Polanski J; Bak A; Gieleciak R; Magdziarz T
    Molecules; 2004 Dec; 9(12):1148-59. PubMed ID: 18007509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FlexE: efficient molecular docking considering protein structure variations.
    Claussen H; Buning C; Rarey M; Lengauer T
    J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a MIP-based alignment and docking in computer-aided drug design.
    Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J
    Proteins; 2004 Aug; 56(3):585-94. PubMed ID: 15229890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
    Srinivasan B; Tonddast-Navaei S; Skolnick J
    Eur J Med Chem; 2015 Oct; 103():600-14. PubMed ID: 26414808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors.
    Muller P; Lena G; Boilard E; Bezzine S; Lambeau G; Guichard G; Rognan D
    J Med Chem; 2006 Nov; 49(23):6768-78. PubMed ID: 17154507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads.
    Böhm HJ
    J Comput Aided Mol Des; 1992 Dec; 6(6):593-606. PubMed ID: 1291628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The computer program LUDI: a new method for the de novo design of enzyme inhibitors.
    Böhm HJ
    J Comput Aided Mol Des; 1992 Feb; 6(1):61-78. PubMed ID: 1583540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2.13 A structure of E. coli dihydrofolate reductase bound to a novel competitive inhibitor reveals a new binding surface involving the M20 loop region.
    Summerfield RL; Daigle DM; Mayer S; Mallik D; Hughes DW; Jackson SG; Sulek M; Organ MG; Brown ED; Junop MS
    J Med Chem; 2006 Nov; 49(24):6977-86. PubMed ID: 17125251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate.
    Zolli-Juran M; Cechetto JD; Hartlen R; Daigle DM; Brown ED
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2493-6. PubMed ID: 12852950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution of the conformation and alignment tensors for the binding of trimethoprim and its analogs to dihydrofolate reductase: 3D-quantitative structure-activity relationship study using molecular shape analysis, 3-way partial least-squares regression, and 3-way factor analysis.
    Dunn WJ; Hopfinger AJ; Catana C; Duraiswami C
    J Med Chem; 1996 Nov; 39(24):4825-32. PubMed ID: 8941396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexibases: a way to enhance the use of molecular docking methods.
    Kearsley SK; Underwood DJ; Sheridan RP; Miller MD
    J Comput Aided Mol Des; 1994 Oct; 8(5):565-82. PubMed ID: 7876901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRO_LIGAND: an approach to de novo molecular design. 6. Flexible fitting in the design of peptides.
    Murray CW; Clark DE; Byrne DG
    J Comput Aided Mol Des; 1995 Oct; 9(5):381-95. PubMed ID: 8594156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening, docking, and dynamics of potential new inhibitors of dihydrofolate reductase from Yersinia pestis.
    Bastos Lda C; de Souza FR; Guimarães AP; Sirouspour M; Cuya Guizado TR; Forgione P; Ramalho TC; França TC
    J Biomol Struct Dyn; 2016 Oct; 34(10):2184-98. PubMed ID: 26494420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from cryptosporidium.
    Bolstad DB; Bolstad ES; Frey KM; Wright DL; Anderson AC
    J Med Chem; 2008 Nov; 51(21):6839-52. PubMed ID: 18834108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.